Bluebird Myeloma Trial Treatment Shows It Could Delay Cancer Progression
Patients those are suffering from advanced multiple myeloma and are treated with bluebird experimental immunotherapy of bio lived for a nearly about a year before their cancer stage got worst, as per data from a small study that was presented on Friday. The treatment named as “bb2121”, is a part of a hot new therapy […]
Continue Reading